Is NiceRx a Spinraza coupon provider?
NiceRx does not provide Spinraza coupons, discount cards or copay cards. We do not offer printable Spinraza manufacturer coupons, Spinraza discounts, rebates, Spinraza savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Spinraza medication with NiceRx.
Spinraza patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Spinraza cheaper if I have insurance?
How much does Spinraza cost without insurance?
Spinraza prices without insurance will vary by retailer.
How much does Spinraza cost with insurance?
Your individual healthcare plan will determine the copay of Spinraza with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is Spinraza?
Spinraza (nusinersen) is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Biogen. It is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide used to treat complex neurological disorder spinal muscular atrophy (SMA) in pediatric and adult patients.
SMA patients are born with a mutation in the SMN1 gene, where they have 2 copies of survival motor neuron 2 (SMN2 gene). Spinraza replaces the missing protein in SMN2 by binding to a sequence in the intron downstream of exon 7 of the SMN2 transcript resulting in an increased amount of the SMN protein. Spinraza is not gene therapy.
What doses of Spinraza are available?
Spinraza is available as an intrathecal injection form, in the following doses: 12 mg/5 mL in a single-dose vial.
Spinraza is delivered directly to the central nervous system. It is injected into the spinal cord. The procedure is known as a lumbar puncture or spinal tap. At baseline and before each dose, obtain a platelet count, coagulation laboratory testing, and spot urine protein testing. Remove 5 mL of cerebrospinal fluid before starting treatment.
Initiate Spinraza treatment with 4 loading doses, with the first three doses administered at 14-day intervals, and the 4th loading dose 30 days after the 3rd dose. Maintenance doses should be given once every 4 months thereafter.
Please read the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Spinraza active ingredients
Spinraza contains nusinersen as the active ingredient. In the sham-controlled studies for patients with infantile-onset and later-onset SMA, 16% of patients with high, normal, or unknown platelet count at baseline developed a platelet level below the lower limit, compared to 14% of sham-controlled patients.
Spinraza side effects
The most common side effects of Spinraza in clinical trials include:
- Lower respiratory infection
- Upper respiratory infection
- Fever, headache, vomiting
- Back pain
- Post-lumbar puncture syndrome
In rare instances, Spinraza can cause more serious adverse effects. These can include:
- Thrombocytopenia and coagulation abnormalities – increased risk for bleeding complications, testing required at baseline and before each dose
- Renal toxicity
Your doctor will assess the benefits of using Spinraza against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions to Spinraza to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Spinraza drug interactions
Other drugs may interact with Spinraza, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.
You should not use Spinraza if you:
- Are allergic to the active ingredient nusinersen
- Are allergic to any of the other ingredients in Spinraza
Talk to your doctor before using Spinraza if you:
- Are taking any of the medications that could interact with Spinraza
- Have a bleeding disorder
- Have a kidney disorder
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Spinraza is the trademark brand name for nusinersen, originally developed by Ionis Pharmaceuticals, and now manufactured by Biogen. A generic version of nusinersen is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Spinraza savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.